BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, January 19, 2026
Home
»
Topics
» Regulatory
Regulatory
RSS
First drug approved in E.U. for multiply relapsed/refractory aggressive NHL
May 11, 2012
FDA approves expanded dose range for schizophrenia drug
May 7, 2012
FDA approves Levaquin for new indication
May 4, 2012
FDA approves new therapy for type 1 Gaucher's disease
May 2, 2012
Afinitor approved in U.S. for new indication
April 30, 2012
FDA approves sNDA for Votrient
April 30, 2012
First medicine approved in E.U. for Cushing's disease
April 25, 2012
Alimera announces first marketing authorization for Iluvien in E.U.
April 25, 2012
Novartis seeking approval in Japan of Glivec for new indication
April 17, 2012
Eisai launches new formulation of rufinamide in U.K.
April 16, 2012
Previous
1
2
…
1034
1035
1036
1037
1038
1039
1040
1041
1042
…
1333
1334
Next
RSS